Application 204737
- Type
- ANDA
- Sponsor
- ALVOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PYRIDOSTIGMINE BROMIDE | PYRIDOSTIGMINE BROMIDE | TABLET, EXTENDED RELEASE;ORAL | 180MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-335 | Pyridostigmine Bromide | Pyridostigmine Bromide | Alvogen, Inc. | ANDA | Current |
| 47781-335 | Pyridostigmine Bromide | Pyridostigmine Bromide | Alvogen, Inc. | ANDA | Current |
| 47781-335 | Pyridostigmine Bromide | Pyridostigmine Bromide | Alvogen, Inc. | ANDA | Current |
| 47781-335 | Pyridostigmine Bromide | Pyridostigmine Bromide | Alvogen, Inc. | ANDA | Current |
| 47781-335 | Pyridostigmine Bromide | Pyridostigmine Bromide | Alvogen, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 10386 | ORIG | 2015-07-07 |